Cargando…
Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation
Prioritization of immunogenic neoantigens is key to enhancing cancer immunotherapy through the development of personalized vaccines, adoptive T cell therapy, and the prediction of response to immune checkpoint inhibition. Neoantigens are tumor-specific proteins that allow the immune system to recogn...
Autores principales: | Borden, Elizabeth S., Buetow, Kenneth H., Wilson, Melissa A., Hastings, Karen Taraszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929516/ https://www.ncbi.nlm.nih.gov/pubmed/35311072 http://dx.doi.org/10.3389/fonc.2022.836821 |
Ejemplares similares
-
Neoantigen Fitness Model Predicts Lower Immune Recognition of Cutaneous Squamous Cell Carcinomas Than Actinic Keratoses
por: Borden, Elizabeth S., et al.
Publicado: (2019) -
Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma
por: Borden, Elizabeth S., et al.
Publicado: (2021) -
High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
por: Adams, Anngela C., et al.
Publicado: (2022) -
The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021) -
The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)